Table 8. Causes of death.
Induction therapy | ||||
---|---|---|---|---|
No | ATG | Alemtuzumab | ||
Cause of death | Graft failure | 1 (1.6%) | 0 (0.0%) | 1 (2.4%) |
BO | 9 (14.8%) | 1 (6.7%) | 3 (7.3%) | |
Infection-not-CMV | 27 (44.3%) | 10 (66.7%) | 26 (63.4%) | |
CMV | 1 (1.6%) | 0 (0.0%) | 0 (0.0%) | |
Cardiovascular | 6 (9.8%) | 0 (0.0%) | 4 (9.8%) | |
Others | 10 (16.4%) | 2 (13.3%) | 2 (4.9%) | |
Acute Rejection | 2 (3.3%) | 0 (0.0%) | 2 (4.9%) | |
Skin and solid malignancies | 4 (6.6%) | 1 (6.7%) | 1 (2.4%) | |
PTLD | 0 (0.0%) | 0 (0.0%) | 1 (2.4%) |